Neutralising antibodies to interferon beta in multiple sclerosis: analytical comparison between two different cytopathic assays

被引：0
|
作者：
Orpez, T.
Oliver, B.
Lopez-Gomez, C.
Mayorga, C.
Fernandez-Sanchez, V. E.
Alonso, A.
Luque, G.
Fernandez, O.
机构：
[1] Fdn IMABIS, Malaga, Spain
[2] Inst Neurosci Clin, Malaga, Spain
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [31] Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis
    Govindappa, Karthik
    Sathish, Jean
    Park, Kevin
    Kirkham, Jamie
    Pirmohamed, Munir
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (11) : 1287 - 1298
  • [32] Assessment of anti-beta-interferon neutralising antibodies status and disease severity in a cohort of multiple sclerosis patients
    Ali, E.
    Farrell, R. A.
    Worthington, V.
    Hennessy, M.
    Counihan, T.
    Giovannoni, G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (09): : 1037 - 1037
  • [33] Titre-dependent impact of neutralising antibodies to beta-interferon in relapsing-remitting multiple sclerosis
    O'Rourke, K
    Hutchinson, M
    MULTIPLE SCLEROSIS, 2005, 11 : S160 - S160
  • [34] Clinical efficacy and neutralising antibodies in multiple sclerosis patients treated with interferon-β
    D'hooghe, MB
    Nagels, G
    Van Remoortel, A
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S254 - S254
  • [35] Three ranges of titres of neutralising antibodies present different risk of loss of interferon-beta biological activity in vivo in multiple sclerosis patients
    Sala, A.
    Capobianco, M.
    Malucchi, S.
    di Sapio, A.
    Caldano, M.
    Marnetto, F.
    Valentino, P.
    Gilli, F.
    Bertolotto, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S206 - S207
  • [36] Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study)
    Magyari, Melinda
    Sondergaard, Helle Bach
    Sellebjerg, Finn
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 141 - 146
  • [37] Study of binding and neutralising antibodies to interferon-β in two groups of relapsing-remitting multiple sclerosis patients
    Oscar Fernández
    Cristobalina Mayorga
    Gloria Luque
    Miguel Guerrero
    Rocío Guerrero
    Laura Leyva
    Antonio León
    Miguel Blanca
    Journal of Neurology, 2001, 248 : 383 - 388
  • [38] Study of binding and neutralising antibodies to interferon-β in two groups of relapsing-remitting multiple sclerosis patients
    Fernández, O
    Mayorga, C
    Luque, G
    Guerrero, M
    Guerrero, R
    Leyva, L
    León, A
    Blanca, M
    JOURNAL OF NEUROLOGY, 2001, 248 (05) : 383 - 388
  • [39] Use of MxA mRNA and neutralising antibodies detection as predictive factors of interferon beta clinical efficacy in multiple sclerosis patients
    Malucchi, S.
    Sala, A.
    Capobianco, M.
    di Sapio, A.
    Marnetto, F.
    Caldano, M.
    Valentino, P.
    Gilli, F.
    Bertolotto, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S206 - S206
  • [40] Antibodies against interferon-beta in multiple sclerosis
    Aarskog, Nina Karin
    Maroy, Tove
    Myhr, Kjell-Morten
    Vedeler, Christian A.
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 212 (1-2) : 148 - 150
12345